Redmile Group’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.81M | Sell |
|
|||||
|
2025
Q1 | $77.8M | Buy |
|
|||||
|
2024
Q4 | $66.5M | Sell |
|
|||||
|
2024
Q3 | $88.1M | Sell |
|
|||||
|
2024
Q2 | $105M | Sell |
|
|||||
|
2024
Q1 | $156M | Sell |
|
|||||
|
2023
Q4 | $210M | Sell |
|
|||||
|
2023
Q3 | $206M | Sell |
|
|||||
|
2023
Q2 | $246M | Buy |
|
|||||
|
2023
Q1 | $203M | Sell |
|
|||||
|
2022
Q4 | $247M | Sell |
|
|||||
|
2022
Q3 | $227M | Sell |
|
|||||
|
2022
Q2 | $238M | Sell |
|
|||||
|
2022
Q1 | $211M | Sell |
|
|||||
|
2021
Q4 | $262M | Buy |
|
|||||
|
2021
Q3 | $199M | Hold |
|
|||||
|
2021
Q2 | $201M | Sell |
|
|||||
|
2021
Q1 | $209M | Buy |
|
|||||
|
2020
Q4 | $476M | Sell |
|
|||||
|
2020
Q3 | $326M | Sell |
|
|||||
|
2020
Q2 | $376M | Sell |
|
|||||
|
2020
Q1 | $233M | Sell |
|
|||||
|
2019
Q4 | $246M | Buy |
|
|||||
|
2019
Q3 | $183M | Sell |
|
|||||
|
2019
Q2 | $284M | Buy |
|
|||||
|
2019
Q1 | $267M | Buy |
|
|||||
|
2018
Q4 | $79.7M | Sell |
|
|||||
|
2018
Q3 | $102M | Sell |
|
|||||
|
2018
Q2 | $164M | Sell |
|
|||||
|
2018
Q1 | $162M | Buy |
|
|||||
|
2017
Q4 | $144M | Sell |
|
|||||
|
2017
Q3 | $166M | Sell |
|
|||||
|
2017
Q2 | $121M | Buy |
|
|||||
|
2017
Q1 | $81.1M | Sell |
|
|||||
|
2016
Q4 | $61.3M | Sell |
|
|||||
|
2016
Q3 | $94.4M | Buy |
|
|||||
|
2016
Q2 | $60.6M | Buy |
|
|||||
|
2016
Q1 | $90.6M | Buy |
|
|||||
|
2015
Q4 | $99.7M | Buy |
|
|||||
|
2015
Q3 | $117M | Buy |
|
|||||
|
2015
Q2 | $89.1M | Buy |
|
|||||
|
2015
Q1 | $63.5M | Sell |
|
|||||
|
2014
Q4 | $57.2M | Buy |
|
|||||
|
2014
Q3 | $34M | Sell |
|
|||||
|
2014
Q2 | $25.6M | Sell |
|
|||||
|
2014
Q1 | $17.6M | Sell |
|
|||||
|
2013
Q4 | $20.3M | Buy |
|
|||||
|
2013
Q3 | $5.74M | Buy |
|
|||||
|
2013
Q2 | $5.53M | Buy |
|